Wordt geladen...
PATH-18. SUBCLASSIFICATION OF LOW-GRADE GLIOMAS CONSIDERING TERT PROMOTER MUTATION AND ATRX LOSS: BEYOND THE 2016 WHO CLASSIFICATION
BACKGROUND: Grade II glioma is a heterogeneous group of various pathologies. 2016 WHO classification defined subgroups of Grade II gliomas based on isocitrate dehydrogenase (IDH) mutation and 1p/19q codeletion status. However, implications of telomerase reverse transcriptase promoter (TERTp) mutatio...
Bewaard in:
| Gepubliceerd in: | Neuro Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216526/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.674 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|